Biography:

Nooshin Peyman is currently working as a Professor in the Department of Health Education and Health Promotion at the Mashhad University of Medical Science. Her research is focused broadly on designing health literacy level-appropriate education based on our findings for both patients and their family caregiver. She works with the interdisciplinary team to enhance health literacy responsiveness across the health and community services system in Iran by building workforce capability and embedding health literacy practices within organizations.

Abstract:

Maternal health literacy during pregnancy is essential in maintaining health of themselves and their children. The aim of this study was to determine the effects of a maternal education intervention based on the self-efficacy theory and health literacy on birth weight. This clinical trial study was performed on 76 pregnant mothers, referred to Mashhad University of Medical Sciences health centers, Mashhad, Iran for routine prenatal checkups in 2016. The participants were assigned to two groups based on multistage cluster sampling method. Study questionnaires included demographic, maternal health literacy, pregnancy outcome and perceived dietary self-efficacy questionnaires, educational intervention including oral presentation, group discussion and multimedia tutorials. The questionnaires were completed at baseline, after intervention and at three months of follow up. The mean age of mothers was 24.92±4.84 years (23.92±4.59 and 25.92±4.94 years in intervention and control groups, respectively). There was no significant difference between the intervention and control groups in terms of age, maternal health literacy and self-efficacy at baseline. Intervention resulted in significant improvement in health literacy (p<0.001) and nutrition self-efficacy (p<0.001) in the intervention group compared to control group. The mean birth weight of children was significantly higher in the intervention group 3324.14±416.12 g compared to the control group 3007.73±468.63 g (p=0.003). The present findings indicate the effectiveness of the designed educational intervention based on self-efficacy theory in improving maternal health literacy and promoting normal birth weight in newborns.

Biography:

Huma Sheikh has been working in Reproductive Health Care for almost last 18 years. She is Gynecologist and Obstetrician and is serving in Government Maternity Hospital, Gujranwala Pakistan.

Abstract:

Statement of Problem: Chronic pelvic pain presents in primary care as frequently as migraine or low back pain. It is a symptom not a diagnosis but has significant impact on women quality of life and carries a heavy economic and social burden. This is affecting as many as 15% women and provides both diagnostic and therapeutic challenge. The objective of study is to evaluate chronic pelvic pain in females of reproductive age at primary health care.

Method: This is a descriptive study which is conducted at government maternity hospital Satellite Town, Gujranwala, Pakistan. A sample of 150 subjects is selected through convenient sampling technique with after taking prior informed consent. The survey was conducted using questionnaires comprising of questions regarding pain, gynecological, medical and surgical history.

Findings: Data was analyzed using SPSS 21 and the results indicated that out of 150 patients 28% presented with sole chronic pelvic pain while 55% presented with vaginal discharge, 7% with infertility, 3% with menstrual irregularities and 7% with dysmenorrhea. Most presenting complaint is vaginal discharge because of lack of hygiene and unsafe sexual practice acquiring infections. Increase in caesarian sections and associated nerve entrapment and pain due to adhesions is also an important reason.

Conclusion: At primary health care with first contact with GP and gynecologist detailed history of the patient and examination is key towards diagnosis. Sexual abuse, unsafe sexual practice has to be enquired in a very sensitive manner. Continuous antenatal care, safe home births, and avoidance of undue surgeries are keys towards prevention of complications and health burden on developing countries.

 

Biography:

Mohamed Zakaria Sayer Dayer is consultant gynecologist and working in the Menoufia University, Egypt.

Abstract:

Data of 92 patients diagnosed with Borderline Ovarian Tumours (BOTs) during the period from 2010 to 2017 in the National Cancer Institute (NCI), Cairo University, Egypt were retrospectively evaluated, median follow up period was 42 months. The mean age at diagnosis was 42.7 yrs. Histopathology was serous in 63%, mucinous in 28.3% and endometrioid in 3.3%. 65 patients (70.7%) had stage IA disease, 17 patients had stage IB disease (18.5%), 4 patients had stage IC disease (4.3%), 2 patients had stage II disease (2.2%) and 4 patients had stage III disease (4.3%) at diagnosis. 49 patients (53.3%) underwent fertility sparing surgery, of which 19 patients underwent unilateral ovarian cystectomy, 5 patients underwent bilateral ovarian cystectomy, 25 underwent unilateral salpingo-oopherectomy. 43 patients (46.7%) underwent radical surgery including hysterectomy, bilateral salpingo-oopherectomy. 39 patients had micropapillary disease (42 %) and 2 patients had microinvasive disease (2.2%) on histopathology. 6 patients (6.5%) had peritoneal implants of which 1 was invasive and 5 were non-invasive. Recurrence rate in the entire study group was 18.5%, 17.6% among patients underwent radical surgery and 82.4% among patients underwent fertility sparing surgery. 12 of the recurrences (70.6%) were borderline whereas, 5 were invasive (29.4%). Stages IA and IB had significantly higher disease free survival than other stages. Patients with micro invasion had significantly lower disease free survival 10.5 (9.52-11.5) vs. 77.6 (70.9-84.1). Radical surgery had significantly higher DFS than fertility sparing surgery 75.8 (70.2-81.4) vs. 68.5 (58.2-78.8).

 

Biography:

George Eleje is currently working as a Senior Lecturer at the Nnamdi Azikiwe University, Nnewi Campus, Nigeria and a Consultant Obstetrician-Gynecologist at the Nnamdi Azikiwe University Teaching Hospital, Nigeria. He is also Research Coordinator at the Effective Care Research Unit, Nnamdi Azikiwe University, Nigeria.

Abstract:

Introduction & Objective: Prophylactic risk-reducing Salpingo-oophorectomy (RRSO) refers to surgical removal of both fallopian-tubes and ovaries in women not thought to have cancer prior to surgical procedure but have a high lifetime risk. Despite previous studies, the role of RRSO in reducing breast and High-grade Serous Cancer (HGSC) of ovarian, tubal and peritoneal origin are uncertain. This study assesses benefits and harms of prophylactic RRSO in women with BRCA1 or BRCA2 mutations.

Method: We searched Cochrane Central Register of Controlled Trials, MEDLINE /Embase Ovid and trial registries, and abstracts with no language restrictions up to July 2017. We included non-randomized trials that used statistical adjustment analyses comparing RRSO versus no RRSO in women without a previous/coexisting gynecological malignancy and in women with a Risk-reducing Mastectomy (RRM). We extracted data and performed meta-analyses of Hazard Ratios (HR) for time-to-event variables and Risk Ratios (RR) for dichotomous outcomes, with 95% Confidence Intervals (CI). We used ROBINS-I 'Risk of bias' assessment tool and quantified inconsistency using I² statistic. We used random-effects models.

Results: Ten cohort studies were included comprising 8087 BRCA1/BRCA2 mutation carriers (2936 surgical and 5151 controls). GRADE assessment certainty of evidence was very low. Overall survival was longer with RRSO compared with no RRSO (HR 0.32, 95% CI 0.19 to 0.54; P<0.001; 3 studies, 2548 women; very low-certainty evidence). HGSC cancer mortality (HR 0.06, 95% CI 0.02 to 0.17; I²=69%; P<0.0001; 3 studies, 2534 women; very low-certainty evidence) and breast cancer mortality (HR 0.58, 95% CI 0.39 to 0.88; I²=65%; P=0.009; 7 studies, 7198 women; very low-certainty evidence) were lower with RRSO compared with no RRSO. No study reported adverse events.

Conclusion: There is very low-certainty evidence that RRSO may increase overall survival and lower HGSC and breast cancer mortality for BRCA1/BRCA2 carriers. Very low-certainty evidence suggests that RRSO reduces the risk of death from HGSC and breast cancer in women with BRCA1 mutations. Evidence for the effect of RRSO on HGSC and breast cancer in BRCA2 carriers was very uncertain due to low numbers. Further research is warranted to explore differential effects for BRCA1 or BRCA2 mutations.